SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/426C3DAA009A8791E02BDDED759BBA43AD6E615ACBECA648F99DBA5BE3D7610D9D35A53AF245CA3FE3E75478A4F9E750>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/426C3DAA009A8791E02BDDED759BBA43AD6E615ACBECA648F99DBA5BE3D7610D9D35A53AF245CA3FE3E75478A4F9E750
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/426C3DAA009A8791E02BDDED759BBA43AD6E615ACBECA648F99DBA5BE3D7610D9D35A53AF245CA3FE3E75478A4F9E750
http://www.w3.org/2000/01/rdf-schema#comment
"Collectively the present data indicate that FTY720 treatment may offer the potential not only to prevent the onset of disease but also to treat memory T cell-mediated autoimmune diseases including inflammatory bowel diseases."
xsd:string
http://purl.uniprot.org/uniprot/#_6057403429806AC1B27272A26DFA2E2AE81EF1039A1F0F0D738D9B0E2909CC713B5482E7CAC4B37A2A805F371A4D90D9
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/426C3DAA009A8791E02BDDED759BBA43AD6E615ACBECA648F99DBA5BE3D7610D9D35A53AF245CA3FE3E75478A4F9E750
http://purl.uniprot.org/uniprot/B1B507
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/426C3DAA009A8791E02BDDED759BBA43AD6E615ACBECA648F99DBA5BE3D7610D9D35A53AF245CA3FE3E75478A4F9E750
http://purl.uniprot.org/uniprot/#_B1B507-mappedCitation-16574986
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/426C3DAA009A8791E02BDDED759BBA43AD6E615ACBECA648F99DBA5BE3D7610D9D35A53AF245CA3FE3E75478A4F9E750